Bleeding and bruising in patients with Ehlers–Danlos syndrome and other collagen vascular disorders
Open Access
- 19 November 2004
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 127 (5), 491-500
- https://doi.org/10.1111/j.1365-2141.2004.05220.x
Abstract
Easy bruising and bleeding are not only characteristic manifestations of clotting and platelet disorders, they are also prominent features in some heritable collagen disorders, such as the Ehlers–Danlos syndromes (EDS). The EDS comprise a heterogeneous group of connective tissue diseases sharing clinical manifestations in skin, ligaments and joints, blood vessels and internal organs. Most EDS subtypes are caused by mutations in genes encoding the fibrillar collagens type I, III and V, or in genes coding for enzymes involved in the post‐translational modification of these collagens. Easy bruising is, to a variable degree, present in all subtypes of EDS, and is because of fragility of the capillaries and the perivascular connective tissues. Vascular fragility affecting medium‐sized and large arteries and veins is typically observed in the vascular subtype of EDS, caused by a molecular defect in collagen type III, an important constituent of blood vessel walls and hollow organs. Extensive bruising, spontaneous arterial rupture, leading to severe internal bleeding or premature death, and rupture of hollow organs, such as the intestine or the gravid uterus are predominant features of this subtype. Haematological studies including evaluation of clotting factors, platelet aggregation and bleeding time are usually normal in patients with EDS, except for the Hess test (Rumple–Leede test), which may be abnormal, indicating capillary fragility. In some forms of EDS confirmation of the clinical diagnosis and subtype is possible with biochemical and molecular studies.Keywords
This publication has 59 references indexed in Scilit:
- The molecular basis of classic Ehlers-Danlos syndrome: A comprehensive study of biochemical and molecular findings in 48 unrelated patientsHuman Mutation, 2004
- The natural history, including orofacial features of three patients with Ehlers–Danlos syndrome, dermatosparaxis type (EDS type VIIC)American Journal of Medical Genetics Part A, 2004
- A Recessive Form of the Ehlers–Danlos Syndrome Caused by Tenascin-X DeficiencyNew England Journal of Medicine, 2001
- Ehlers‐Danlos syndromes: Revised nosology, Villefranche, 1997American Journal of Medical Genetics, 1998
- DDAVP Therapy Controls Bleeding in Ehlers-Danlos SyndromeJournal of Pediatric Hematology/Oncology, 1997
- Cerebrovascular complications in Ehlers‐Danlos syndrome type IVAnnals of Neurology, 1995
- Ehlers-Danlos syndrome type VI: Clinical manifestations of collagen lysyl hydroxylase deficiencyThe Journal of Pediatrics, 1989
- New Collagens, New ConceptsAnnual Review of Cell and Developmental Biology, 1988
- Spontaneous arterial perforation: The Ehlers-Danlos specterJournal of Vascular Surgery, 1987
- Ehlers-Danlos syndrome presenting with juvenile destructive periodontitisBritish Dental Journal, 1979